AU2013393832B2 - Analytical method for detecting sulfated oligosaccharides - Google Patents

Analytical method for detecting sulfated oligosaccharides Download PDF

Info

Publication number
AU2013393832B2
AU2013393832B2 AU2013393832A AU2013393832A AU2013393832B2 AU 2013393832 B2 AU2013393832 B2 AU 2013393832B2 AU 2013393832 A AU2013393832 A AU 2013393832A AU 2013393832 A AU2013393832 A AU 2013393832A AU 2013393832 B2 AU2013393832 B2 AU 2013393832B2
Authority
AU
Australia
Prior art keywords
mobile phase
hilic
poly
sample
sulfated oligosaccharides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU2013393832A
Other versions
AU2013393832A1 (en
Inventor
Helen CHAO
YungTe CHIANG
Imin HUANG
ChungYao WANG
ChiaYen WU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scinopharm Taiwan Ltd
Original Assignee
Scinopharm Taiwan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scinopharm Taiwan Ltd filed Critical Scinopharm Taiwan Ltd
Publication of AU2013393832A1 publication Critical patent/AU2013393832A1/en
Application granted granted Critical
Publication of AU2013393832B2 publication Critical patent/AU2013393832B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/30—Partition chromatography
    • B01D15/305—Hydrophilic interaction chromatography [HILIC]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8836—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving saccharides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph

Abstract

The present invention describes an analytical method for detecting and quantitating poly-sulfated oligosaccharides, including Fondaparinux sodium, using hydrophilic interaction ultra-performance liquid chromatography (HILIC-UPLC) coupled with a charged aerosol detector (CAD) or a mass spectrometer (MS). This analytical method provides in-process control in a total synthesis of highly sulfated oligosaccharides by separation, quantification and mass identification. Systems and conditions utilizing such methods are also provided.

Description

ANALYTICAL METHOD FOR DETECTING SULFATED OLIGOSACCHARIDES CROSS-REFERENCES TO RELATED APPLICATIONS [00011 Not Applicable
BACKGROUND OF THE INVENTION
[0002] Hepamoid (Heparin and Heparan sulfate) is a well-known regulatory mediator in numerous important biological processes, Heparnoid and its derivative, low-molecular weight heparin (LMWH), have been used as clinical anticoagulant drugs during surgery and kidney dialysis. For example, Fondaparinux sodium (CAS 114870-03-0) is a member of oligosaccharides / heparins with a chemical name of 0-[2-Deoxy-6-0-sulfo-2-(sulfoamino)-aipha-D-glucopyranosyl]-(1 --4)-0-(beta-D-gl ucopyranurosonyl)-( 1 -4)-0-[2-deoxy-3,6-di-O- sulfo-2“(sulfoamino)-alpha-D-g]ucopyranosyl]-(l-4)-0-(2-0-sulfo-alpha-L-idopyranurosony[)-(1 —4)-0-[2-deoxy-l-0-methyl-6-0-sulfo-2-(sulioamino)-alpha-D-giucopyranoside] decasodium salt, and was developed by Choay, S.A. (see IJ.S. Patent No. 4,818,816). The compound is a synthetic pentasaccharide Factor Xa inhibitor which is used as an anticoagulant drug for the prevention of deep vein thrombosis in patients who have had orthopedic surgery as well as for the treatment of deep vein thrombosis and pulmonary embolism. Fondaparinux sodium was approved by the United States Food and Drug Administration in 2001, marketed under the trade name Arixtram. Fondaparinux sodium is administrated subcutaneously, [0003] Analytical methods for heparin and heparan sulfate, traditionally involved reverse phase chromatographic and mass spectrometric (MS) techniques, but have limitations due to the high polarity, structural diversity, and sulfate lability of heparan sulfate. For instance, the quantitation of synthetic poly-sulfated oligosaccharides using MS is restricted because the ionization of poly-sulfated oligosaccharides tends to form various types of fragments and metal cation-coupled adducts with loss of sulfate groups. This leads to greater spectral complexity and signal splitting. In addition, it is difficult to demonstrate the degree of loss of sultate groups during the analysis because it depends on the concentration and charge state of sulfated oligosaccharides. Improved analytical methods tor poly-sulfated oligosaccharides have been the target of a number of research groups.
[0004] Catalin et ah ( Anal Chem. 2009, 81, 3485) and Tatiana et al, ( Anal Chem. 2006, 78, 1774) have each described the characterization of poly-sulfated oligosaccharides by using electrospray ionization mass spectrometry (ESI-MS) and matrix-assisted laser desorption and ionization mass spectrometry (MALDl-MS). However, the current methods using the coupling of liquid chromatograph (LC) with mass spectrometry does not provide on-line in-process resolution/separation of peaks and hence the identification ot the structure related impurities and/or quantitation of the poly-sulfated oligosaccharides cannot be established during the production of synthetic poly-sulfated oligosaccharides. |§00S] Imanari. et al. ( J. Chromatogr., A 1996,720, 275.) and Rice el al. ( J. Anal. Biochem, 1985, 150, 325.) illustrated the analytical method of poly-sulfated oligosaccharides by strong anion exchange chromatography (SAX). This method appears to separate highly sulfated oligosaccharides via the difference in charge density, but it remains difficult to directly couple SAX with a detection method like MS due to the use of nonvolatile salt in the mobile phase composition.
[0006] Still other problems associated with analytical methods for poly-sulfated oligosaccharides are due to the non-chromophore characteristics (very low' UV absorption) of poly-sulfated oligosaccharides, which can restrict the use of traditional UV detectors. The other universal detectors such as refractive index (RI) and evaporative light scattering (ELSD) also lack enough detecting sensitivity for poly-sulfate oligosaccharides.
[00Θ7] Although some methods of detection of poly-sulfated oligosaccharides have been disclosed, a number of limitations remain. Thus, there is a continuing need for improved methods for the separation, quantitation and mass identification of poly-sulfated oligosaccharides. The stable, sensitive and in-process control (IPC) methods disclosed herein address this need and other needs.
BRIEF SUMMARY OF THE INVENTION
[0007a] A first aspect of the invention provides for a method for detecting and quantitating one or more poly-sulfated oligosaccharides in a sample, the method comprising: (a) subjecting the sample to chromatography on a hydrophilic interaction ultra-performance liquid chromatography (HILIC-UPLC) column having an amide-bonded stationary phase and a mobile phase, to separate the one or more poly-sulfated oligosaccharides from any structure related impurities; and (b) detecting and quantitating the poly-sulfated oligosaccharides in the sample using a charged aerosol detector (CAD).
[0007b] A second aspect of the invention provides for a method for detecting and quantitating fondaparinux in a sample, the method comprising: (a) subjecting the sample to chromatography on a hydrophilic interaction ultra-performance liquid chromatography (HILIC-UPLC) column having an amide-bonded stationary phase and a mobile phase, to separate fondaparinux from any structure related impurities, wherein the mobile phase used in the HILIC-UPLC column comprises acetonitrile and ammonium formate in a concentration of from about 100 mM to about 200 mM; and (b) detecting and quantitating fondaparinux in the sample using a charged aerosol detector (CAD).
[0008] Provided herein is a method for detecting poly-sulfated oilgosaccharides, using a hydrophilic interaction ultra-performance liquid chromatography (HILIC-UPLC) coupled with a charged aerosol detector (CAD) or a mass spectrometer (MS). The methods provided herein allow for improved peak resolution thereby allowing for subsequent quantitation of poly-sulfated oligosaccharides and/or impurities in the sample.
[0009] The use of HILIC overcomes the challenge of retaining and separating extremely polar oligosaccharides. The retention mechanism for HILIC is very intricate and is a multi-modal combination of liquid-liquid partitioning, adsorption, ionic interaction and hydrophobic interaction. Therefore, HILIC, in comparison to reverse phase liquid chromatography (RPLC), provides unique selectivity and retention characteristics.
[0010] As provided herein, the stationary phase used in HILIC column is, in one group of embodiments, an amide-bonded stationary phase.
[0011] In another embodiment, the mobile phase used in HILIC column comprises a salt. In one group of embodiments, the salt is ammonium formate. The use of ammonium formate, in comparison to pyridinium formate and ammonium acetate, provides better performance for retention, selectivity and low noise level baseline.
[0012] In some embodiments, the concentration of the salt is higher than 50 mM. In some selected embodiments, the concentration is higher than 100 mM. Typically, the molar strength of the salt additive in the mobile phase composition can have a significant impact on chromatographic retention, selectivity and sensitivity. As the molarity of the salt additive increases, the ionic strength of the mobile phase and the solute is overpowered by the liquid-liquid partitioning interaction which dominates the retention mechanism rather than the ion exchange effect. However, it has now been discovered that in the case of acidic analytes, such as poly-sulfated oligosaccharides, retention is enhanced as the molarity of the salt additive increases. In particular, the resolution of peaks is further improved as the salt concentration is increased from 50 mM to about 200 mM.
[0013] In one group of embodiments, the solvent of the mobile phase used in the HILIC column is acetonitrile.
[0014] In some embodiments, the detector used for the quantitation of poly-sulfated oligosaccharides is a charged aerosol detector (CAD), During the analysis using CAD, aerosol particles are charged with an ionized gas (typically nitrogen). After the removal of high-mobility particles (mainly excess N2 ions), the aerosol particles are then electrically measured. Most iniDortantly, the method has been demonstrated to provide a uni form response for nonvolatile analytes independent of their nature. Thus, the combination of (1) a separation technique utilizing HILIC, or HILIC-UPLC, and (2) a detection technique such as MS or CAD allows for detection, identification and/or quantification of poly-sulfated thereby providing an effective way for analysis of synthetic poly-sulfated oligosaccharides.
[0015] In accordance with one selected embodiment of the present invention, the poly-sulfated oligosaccharide detected and/or quantitated by the methods described herein is Fondaparinux sodium.
BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1(a) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using Merck, Sequent Zic®-Hi!ic (3.Sum 2.1><250mm).
[0017] Figure 1(b) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using Merck, Sequent Zic®-pHibe (Sum 4.6x150mm).
[0018] Figure 1(c) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using Phenomenex, Synergi Polar-RP (4um 4,6x250mm), [0019] Figure 1(d) provides the chromatograms of ΗILIC-CAD for Fondaparinux Sodium using Phenomenex, Synergi Fusion-RP (4um 4.6x150mm).
[0020] Figure 1(e) provide the chromatograms of HILIC-CAD for Fondaparinux Sodium using Sepax Polar-Pyridine (1.8um 2.1 x 150mm).
[0021] Figure 1(1) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using ES, Epic Dio] (1.7urn 2.1 x 150mm).
[0022] Figure 1(g) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using Waters, Acquity BEH HILIC (1.7um 2.1x150mm).
[0023] Figure 1(h) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using Waters, Acquity BEH Amide (1.7um 2.1 *150mm).
[0024] Figure 2 provides the chromatogram for Fondaparinux Sodium using Waters, BEH Amide column (a) full scale and (h) expanded scale.
[0025] Figure 3 provides the chromatograms in expanded scale of the drug substance analyzed using different types of salt (a) 50 mM ammonium formate (b) 100 mM ammonium formate (c) 100 mM pyridinium formate and (d) 50 mM ammonium acetate
[0026] Figure 4 provides the chromatograms in expanded scale of the drug substance analyzed using various concentrations of ammonium formate (in expanded scale) (a) 50 mM (b) 100 mM (c) 125 mM (d) 150 mM (e) 175 mM and (f) 200 mM.
[0027] Figure 5 provides the chromatograms in expanded scale of the drug substance analyzed using different organic solvents to he mobile phase (a) mobile phase A: 200 mM ammonium formate; mobile phase B: acetone and acetonitrile, 1/1 (b) mobile phase A: 200 mM ammonium formate; mobile phase B: acetonitrile.
DETAILED DESCRIPTION OF THE INVENTION I. General [0028] Provided herein is a straightforward in-process analytical method developed tor poly-sulfated oligosaccharides involving the application of HIL1C-UPLC, CAD and MS for separation, quantification and mass identification, respectively. The in-process control (1PC) during manufacturing is a key for ensuring quality control in a total synthesis of highly sulfated oligosaccharides. The analytical methods described herein are usable as IPC methods. Advantageously, the analytical methods described herein are stable, easy to use, sensitive, and ensure the production of a quality chemical entity within the expected yields. II. Embodiments of the Invention [0029] In view of the above, provided herein is method for detecting and quantitating one or more poly-sulfated oligosaccharides in a sample, the method comprising: (a) subjecting said sample to chromatography on a hydrophilic interaction ultra-performance liquid chromatography (HILIC-UPLC) column coupled with a charged aerosol detector (CAD) or a mass spectrometer (MS), wherein the stationary phase used in H1LIC column is an amide-bonded stationary phase; and (b) determining the amount of poly-sulfated oligosaccharides in the sample.
[0030] The samples used in the present methods are typically the output of synthetic production methods of poly-sulfated oligosaccharides. As a result, samples of the final step in the synthetic procedures can be analyzed according to the present methods by selecting aliquots of reaction mixtures. The sampling of reaction mixtures allows for detection and/or identification and/or quantitation of impurities and/or poly-sulfated oligosaccharides. The sampling of reaction mixture also allows for determination of the extent ot completion of a reaction. Alternatively, the final product can he subjected to the present methods to determine if further purification is needed, [0031] The conditions for chromatography using hydrophilic interaction ultra-performance liquid chromatography will generally involve those conditions known to one of skill in the art, including, but not limited to column selection (size, length and stationary phase) as well as the mobile phase and/or pH of the mobile phase, [0032] Selection of a column will generally involve selection from commercially prepared column such as those available from Waters, ThermoFisher, Merck, Phenomenex, Shodex, Nucleosil, and Sepax. In one group of embodiments, the column has a stationary phase ot neutral charge (e.g., diol phase or amide phase), a charged stationary phase (e.g., silica phase, aminopropyl phase), or a zwitterionic stationary phase. In one selected group of embodiments, the stationary phase is an amide-bonded stationary phase. Examples 1-10 illustrate the results obtained from the use of various stationary phases using the .methods described herein.
[0033] One of skill in the art will appreciate that flow rates will also affect the separation and resolution obtained.
[0034] The solvent used in the mobile phase is generally a polar, aprotic organic solvent or a mixture of polar, aprotic organic solvents. In one group of embodiments, the solvent of the mobile phase used in HTLIC column is acetonitrile, acetone or a mixture of acetonitrile and acetone. Examples 13a-13d Illustrate the effect of various solvents and/or mixtures of solvents in the detection and/or quantitation of poly-sulfated oligosaccharides using the methods described herein.
[0035] In other embodiments, the mobile phase will also comprise a salt, generally a salt selected from ammonium formate, pyridinium formate and ammonium acetate, and mixtures thereof. In certain selected embodiments, the mobile phase will comprise ammonium formate.
In an additional group of embodiments, the mobile phase comprises a salt selected from ammonium citrate and/or ammonium oxalate. Examples 1 la-1 Id illustrate the effect of various salts in the mobile phase in the detection and/or quantitation of poly-sulfated oligosaccharides using the methods described herein.
[0036] The concentra tion of the salt used in the mobile phase will generally be from 25 to about 400 mM, though some optimal results are found when the salt is present in the mobile phase at concentrations of from 50 to about 200 mM. hi some embodiments, the salt is present in the mobile phase at concentrations of about 50-100 mM, from about 100-200 mM, and from about 75 to 175 mM. Examples 12a-12d illustrate the effect of various salt concentrations on peak resolution and peak width during the detection and/or quantitation of poly-sulfated oligosaccharides, when using the methods described herein, by employing ammonium formate as the salt, [0037] In specific embodiments, the methods described above are useful for detection and/or quantitation of the poly-sulfated oligosaccharide fondaparinux having the structure:
[0038] in another aspect, provided herein is a method for detecting and quantitating fondaparinux in a sample, the method comprising: (a) subjecting said sample to chromatography on a hydrophilic interaction ultraperformance liquid chromatography (HILIC-UPLC) column coupled with a charged aerosol detector (CAD) or a mass spectrometer (MS), wherein the stationary phase used in HILIC column is an amide-bonded stationary phase, the mobile phase used in said chromatography is acetonitrile, and the mobile phase comprises ammonium formate in a concentration of from about 100 mM to about 200 raM; and (b) determining the amount of fondaparinux in the sample [0039] As used above and herein, “determination” of the amount of fondaparinux in the sample, or “quantitation of fondaparinux” is effected in one or more ways which are readily available to one of skill in the art. Generally, instruments for UPLC-MS - and/or CAD are sold with pre-installed programs and/or algorithms which can calculate the relative amounts of substances in a sample (e.g., by calculating the areas under the peaks and/or measuring relative-intensities of peaks). According to the response of the instrument and the concentrations of a series of external standards, an external calibration curve can be obtained by using the conventional regression analysis. The sample concentration can then be determined by the external calibration curve. As used above and herein, “detection” (e.g., of fondaparinux and/or impurities) in a sample comprises, in an exemplary embodiment, the recording of chromatograms using the methods described herein (e.g., by use of HILIC-UPLC) and peak identification using a coupled techinque such as CAD or MS thereby confirming (detecting) the presence or absence of fondaparinux and/or impurities in the sample. ΙΪΙ, Examples [0040] The following examples are presented to describe the invention in further detail. However, the present invention is by no means restricted to the specific embodiments described herein.
Instrument [0041] The instruments involved in UPLC-MS study are Ultimate 3000 (UPLC) and micrOTOF-Q Π™ (MS) which were manufactured by Thermo Fisher Dionex and Bruker Daltonics, respectively. The instruments involved in UPLC-CAD are ACQUITY UPLC® System and Thermo Scientific Dionex Ultra CAD which were manufactured by Waters Corporation and Thermo Fisher Dionex, respectively.
Parameters [0042] The conditions for analysis are set forth below.
[0043] 1. An Amide-HILiC type column is used as the analytical column for analyzing poly-sulfonated oligosaccharides.
[0044] 2. The concentration of ammonium formate used in the mobile phase is 100 mM or higher than 100 mM.
[0045] 3. The volume proportion of ammonium formate : acetonitrile in the mobile phase composition is in the range of 95% - 5% : 5% - 95%.
[0046] 4. The range of flow rate used in the examples below is 0.4 mL/min - 1 mL/min
[0047] 5. The range of column temperatures used in the methods described herein is 10°C --70°C
[0048] 6. The range of nebulization temperature of charged aerosol detector used in this method is 10°C - 30°C
[0049] 7. The concentration of testing sample is from 15 pg/mL to 30 mg/niL.
[0050] 8. The injection volume of testing sample is from 1 μ to 5 p.L.
Sample Preparation [0051] The sample is dissolved in a mixture of water and acetonnitriie (1:1; 30mg/mL). Examples 1-10 Comparison of different types of HILIC columns and general LC conditions [0052] The sample prepared as above is analyzed by different types of HILIC columns as shown in Table 1. The chromatograms recorded using various columns are shown in Figures l(a)~(h) and peak identification of Fondaparinux was confirmed by LC-MS.
Table 1
[0053] In maj ority of Exampl es 1 -10, the peak of Fondaparinux was found to be asymmetric with a poor separation from the impurities with one exception, the ease of Waters BEH Amide column. The LC conditions for Waters BEH Amide were optimized and a typical chromatogram is shown in Figure 2, This study demonstrates that the amide type of HILIC column provides a relatively better choice for the analysis of this synthetic poly-sulfated pentasaccharides among various types of HILIC columns.
Examples lla-lld Effect of various salts .
[0054] Three different salts, ammonium formate, pyridinium formate and ammonium acetate were compared. The analysis condition is shown in Table 2. The results are shown in Figure 3.
Table 2
[0055] The best chromatographic performance in terms of retention, selectivity and a low noise level baseline was the mobile phase containing ammonium formate salt, at both 50 mM and 100 mM concentration levels (Figure 3a and 3b, respectively). Pyridinium formate (Figure 3c) and ammonium acetate (Figure 3d) showed higher baseline noise and less retention for the analyte of interest. Based on the study, ammonium formate was chosen to be the salt additive in the mobile phase composition.
Examples 12a~12f Effect of salt concentrations [0056] Mobile phase compositions containing various concentrations of ammonium formate salt were studied to optimize the LC conditions. The concentrations of ammonium formate for Examples 12a~12f are provided in Table 3. The representative chromatograms are shown in Figure 4.
Table 3
[0057] The impurity profile was found to be very similar for chromatograms obtained with 50 mM and 100 mM salt concentrations (Figures 4a and 4b). As the salt concentration increased, a small peak (marked with a dark triangle, see figures 4d, 4e and 4f), right before the main peak, Fondaparinux, was observed. The resolution of this new peak from the main peak was further improved as the salt concentration increased from 150 mM: to 200 mM of ammonium formate.
In addition, it was clear that the bandwidth of the main peak narrowed as the salt concentration increased to 175 mM; no further improvement on resolution and peak shape was observed when the salt concentration was increased beyond 175 mM.
Examples 13a-13b Effect of solvent [0058] Examples 13a and 13b use the mixtures of acetonitrile and acetone and acetonitrile respectively as the solvent of the mobile phase for analyzing Fondaparinux Sodium according to the present invention. Although the results shown in Figure 5 indicate no obvious difference in selectivity between acetonitrile system and mixture (acetonitrile and acetone) system, a higher back pressure was observed in the system comprising the acetone/acetonitrile mixture than m the acetonitrile system.
[0059] Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, one of skill in the art will appreciate that certain changes and modifications may be practiced within the scope of the appended claims. In addition, each reference provided herein is incorporated by reference in its entirety to the same extent as if each reference was individually incorporated by reference. Where a conflict exists between the instant application and a reference provided herein, the instant application shall dominate.

Claims (10)

  1. Claims:
    1. A method for detecting and quantitating one or more poly-sulfated oligosaccharides in a sample, the method comprising: (a) subjecting the sample to chromatography on a hydrophilic interaction ultra-performance liquid chromatography (HILIC-UPLC) column having an amide-bonded stationary phase and a mobile phase, to separate the one or more poly-sulfated oligosaccharides from any structure related impurities; and (b) detecting and quantitating the poly-sulfated oligosaccharides in the sample using a charged aerosol detector (CAD).
  2. 2. The method of claim 1, wherein the mobile phase used in the HILIC-UPLC column comprises a solvent and a salt.
  3. 3. The method of claim 2, wherein the salt is selected from ammonium formate, pyridinium formate and ammonium acetate.
  4. 4. The method of claim 3, wherein the salt is ammonium formate.
  5. 5. The method of claim 3, wherein the salt is ammonium formate and is present in the mobile phase at a concentration of from about 50 mM to 300 mM.
  6. 6. The method of claim 5, wherein the concentration of ammonium formate in the mobile phase is from about 100 mM to 200 mM.
  7. 7. The method of claim 2, wherein the solvent of the mobile phase used in the HILIC-UPLC column is acetonitrile, acetone or a mixture of acetonitrile and acetone.
  8. 8. The method of claim 2, wherein the solvent of the mobile phase used in HILIC-UPLC column is acetonitrile.
  9. 9. The method of claim 1, wherein the poly-sulfated oligosaccharide is fondaparinux having the structure:
  10. 10. A method for detecting and quantitating fondaparinux in a sample, the method comprising: (a) subjecting the sample to chromatography on a hydrophilic interaction ultra-performance liquid chromatography (HILIC-UPLC) column having an amide-bonded stationary phase and a mobile phase, to separate fondaparinux from any structure related impurities, wherein the mobile phase used in the HILIC-UPLC column comprises acetonitrile and ammonium formate in a concentration of from about 100 mM to about 200 mM; and (b) detecting and quantitating fondaparinux in the sample using a charged aerosol detector (CAD).
AU2013393832A 2013-07-11 2013-07-11 Analytical method for detecting sulfated oligosaccharides Expired - Fee Related AU2013393832B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2013/050147 WO2015005928A1 (en) 2013-07-11 2013-07-11 Analytical method for detecting sulfated oligosaccharides

Publications (2)

Publication Number Publication Date
AU2013393832A1 AU2013393832A1 (en) 2016-02-04
AU2013393832B2 true AU2013393832B2 (en) 2017-11-30

Family

ID=52280428

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013393832A Expired - Fee Related AU2013393832B2 (en) 2013-07-11 2013-07-11 Analytical method for detecting sulfated oligosaccharides

Country Status (8)

Country Link
EP (1) EP3019861A4 (en)
JP (1) JP6208866B2 (en)
KR (1) KR20160030963A (en)
CN (1) CN105431733B (en)
AU (1) AU2013393832B2 (en)
CA (1) CA2917460A1 (en)
IL (1) IL243405A0 (en)
WO (1) WO2015005928A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109633003A (en) * 2018-12-26 2019-04-16 成都普思生物科技股份有限公司 Radix Polygalae mouth mountain ketone III and 3,6 in a kind of measurement Radix Polygalae, the method for-two mustard acyl cane sugar contents

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3161128B1 (en) 2014-06-26 2018-09-26 Regeneron Pharmaceuticals, Inc. Methods and compositions for targeted genetic modifications and methods of use
JP6706497B2 (en) * 2015-12-24 2020-06-10 昭和電工株式会社 Method for separating and analyzing hydrophilic compounds
CN105628820A (en) * 2016-01-08 2016-06-01 东营天东制药有限公司 Fast detection method for free sulfate ion in production process of low molecular heparin
US11510871B2 (en) 2016-09-16 2022-11-29 Leukocare Ag Method for producing low viscous and highly concentrated biopharmaceutical drug products in liquid formulation
EP3512939A1 (en) 2016-09-16 2019-07-24 Leukocare AG A novel method for obtaining efficient viral vector-based compositions for vaccination or gene therapy
WO2018235904A1 (en) * 2017-06-22 2018-12-27 昭和電工株式会社 Separation/analysis method for mixture of oligonucleotides
CN109254101B (en) * 2017-07-13 2021-07-09 中国科学院大连化学物理研究所 Method for purifying and analyzing breast milk acid oligosaccharide
CN109459523B (en) * 2017-09-06 2022-11-08 上海绿谷制药有限公司 Method for measuring weight average molecular weight and content of acidic sugar soluble salt
WO2020020152A1 (en) * 2018-07-24 2020-01-30 深圳市海普瑞药业集团股份有限公司 Method for analyzing nitrous acid degradation product of dalteparin sodium and application thereof
WO2020020145A1 (en) * 2018-07-26 2020-01-30 深圳市海普瑞药业集团股份有限公司 Method for analyzing sugar chain distribution of low molecular heparin and use thereof
CN111239311A (en) * 2018-11-28 2020-06-05 中国科学院大连化学物理研究所 Analysis method of acid sugar and acid sugar derivative in infant excrement
CN110161147A (en) * 2019-06-19 2019-08-23 北京三元食品股份有限公司 The high-throughput quantification measuring method of free oligosaccharides in cream

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2667137A1 (en) * 2005-11-08 2007-05-18 Suomen Punainen Risti, Veripalvelu Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof
WO2008150488A1 (en) * 2007-06-01 2008-12-11 Laboratory Corporation Of America Holdings Methods and systems for quantification of peptides and other analytes
US8696917B2 (en) * 2009-02-09 2014-04-15 Edwards Lifesciences Corporation Analyte sensor and fabrication methods
EP2306199A1 (en) * 2009-09-29 2011-04-06 Academisch Ziekenhuis Leiden Acting Under The Name Leiden University Medical Center Reductive amination and analysis of carbohydrates using 2-picoline borane as reducing agent
CN102101875A (en) * 2009-12-16 2011-06-22 中国科学院大连化学物理研究所 Method for purifying and separating oligosaccharides
US9259389B2 (en) * 2009-12-18 2016-02-16 Endotis Pharma Pharmaceutical oral dosage form containing a synthetic oligosaccharide
CA2784906A1 (en) * 2010-01-07 2011-07-14 Polymedix, Inc. Anti-heparin compounds
CN102759596B (en) * 2012-07-09 2014-08-20 山东大学 Method for detecting low-molecular-weight heparin by combining ion pair reversed phase chronmatogaphy and mass spectrum

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JOSÉ M. CINTRÓN ET AL, "Hydrophilic interaction chromatography with aerosol-based detectors (ELSD, CAD, NQAD) for polar compounds lacking a UV chromophore in an intravenous formulation", J OF PHARMACEUTICAL AND BIOMED ANAL, vol. 78-79 *
R.REID TOWNSEND ET AL, "Multimode High-Performance Liquid Chromatography of Fluorescently Labeled Oligosaccharides from Glycoproteins", ANALYTICAL BIOCHEMISTRY, (19960801), vol. 239, no. 2 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109633003A (en) * 2018-12-26 2019-04-16 成都普思生物科技股份有限公司 Radix Polygalae mouth mountain ketone III and 3,6 in a kind of measurement Radix Polygalae, the method for-two mustard acyl cane sugar contents

Also Published As

Publication number Publication date
CN105431733A (en) 2016-03-23
EP3019861A1 (en) 2016-05-18
IL243405A0 (en) 2016-02-29
JP2016524166A (en) 2016-08-12
WO2015005928A1 (en) 2015-01-15
EP3019861A4 (en) 2017-02-22
CA2917460A1 (en) 2015-01-15
AU2013393832A1 (en) 2016-02-04
CN105431733B (en) 2019-01-22
KR20160030963A (en) 2016-03-21
JP6208866B2 (en) 2017-10-04

Similar Documents

Publication Publication Date Title
AU2013393832B2 (en) Analytical method for detecting sulfated oligosaccharides
Pereira Porous graphitic carbon as a stationary phase in HPLC: theory and applications
Bhardwaj et al. A review: HPLC method development and validation
Chaves et al. Microextraction in packed sorbent for analysis of antidepressants in human plasma by liquid chromatography and spectrophotometric detection
Kubica et al. Modern approach for determination of lactulose, mannitol and sucrose in human urine using HPLC–MS/MS for the studies of intestinal and upper digestive tract permeability
Prasanthi et al. Development and validation of RP-HPLC method for simultaneous estimation of rifampicin, isoniazid and pyrazinamide in human plasma
Jiang et al. Determination of carboplatin in human plasma using HybridSPE-precipitation along with liquid chromatography–tandem mass spectrometry
Selvadurai et al. Determination of deflazacort in human plasma by liquid chromatography-mass spectrometry after liquid-liquid extraction and its application in human pharmacokinetics studies
Ito et al. A full validated hydrophilic interaction liquid chromatography–tandem mass spectrometric method for the quantification of oxaliplatin in human plasma ultrafiltrates
Ji et al. Development of a modified quick, easy, cheap, effective, rugged, and safe method based on melamine sponge for multi-residue analysis of veterinary drugs in milks by ultra-performance liquid chromatography tandem mass spectrometry
Wu et al. Simultaneous determination of six alkaloids in blood and urine using a hydrophilic interaction liquid chromatography method coupled with electrospray ionization tandem mass spectrometry
Salas et al. Hydrophilic interaction liquid chromatography coupled to high-resolution mass spectrometry to determine artificial sweeteners in environmental waters
US9441053B2 (en) Analytical method for detecting sulfated oligosaccharides
Duan et al. Rapid determination of nine haloacetic acids in water using ultra-performance liquid chromatography-tandem mass spectrometry in multiple reactions monitoring mode
Havlíková et al. HILIC UHPLC–MS/MS for fast and sensitive bioanalysis: accounting for matrix effects in method development
Abdallah HPLC and densitometric TLC methods for simultaneous determination of gemifloxacin with some co-administered drugs in human plasma
Ito et al. Quantification of intact carboplatin in human plasma ultrafitrates using hydrophilic interaction liquid chromatography–tandem mass spectrometry and its application to a pharmacokinetic study
Pinto et al. Development and validation of a stability‐indicating HPLC method for topiramate using a mixed‐mode column and charged aerosol detector
Ghassempour et al. Monitoring of N-nitrosodiethanolamine in cosmetic products by ion-pair complex liquid chromatography and identification with negative ion electrospray ionization mass spectrometry
Yaroshenko et al. Chromatographic determination of sildenafil in blood plasma using spectrophotometric and mass-spectrometric detection
Bobin-Dubigeon et al. Development and validation of an improved liquid chromatography–mass spectrometry method for the determination of pemetrexed in human plasma
Nemutlu et al. HILIC based LC/MS for metabolite analysis
Sahoo et al. Solid phase extraction and quantification of diclofenac sodium in human plasma by liquid chromatography-tandem mass spectrometry
Hewavitharana et al. Separation of highly charged compounds using competing ions with hydrophilic interaction liquid chromatography–Application to assay of cellular nucleotides
Wang et al. Application of solvent demulsification dispersive liquid–liquid microextraction for nicotine and cotinine measurement in human urine combined with hydrophilic interaction chromatography tandem mass spectrometry

Legal Events

Date Code Title Description
MK25 Application lapsed reg. 22.2i(2) - failure to pay acceptance fee